For: | El-Azab MF, Wakiel AE, Nafea YK, Youssef ME. Role of cannabinoids and the endocannabinoid system in modulation of diabetic cardiomyopathy. World J Diabetes 2022; 13(5): 387-407 [PMID: 35664549 DOI: 10.4239/wjd.v13.i5.387] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v13/i5/387.htm |
Number | Citing Articles |
1 |
Alexandru Vasincu, Răzvan-Nicolae Rusu, Daniela-Carmen Ababei, Monica Neamțu, Oana Dana Arcan, Ioana Macadan, Sorin Beșchea Chiriac, Walther Bild, Veronica Bild. Exploring the Therapeutic Potential of Cannabinoid Receptor Antagonists in Inflammation, Diabetes Mellitus, and Obesity. Biomedicines 2023; 11(6): 1667 doi: 10.3390/biomedicines11061667
|
2 |
Hebaallah Mamdouh Hashiesh, Sheikh Azimullah, Mohamed Fizur Nagoor Meeran, Dhanya Saraswathiamma, Seenipandi Arunachalam, Niraj Kumar Jha, Bassem Sadek, Ernest Adeghate, Gautam Sethi, Alia Albawardi, Saeeda Al Marzooqi, Shreesh Ojha. Cannabinoid 2 Receptor Activation Protects against Diabetic Cardiomyopathy through Inhibition of AGE/RAGE-Induced Oxidative Stress, Fibrosis, and Inflammasome Activation. Journal of Pharmacology and Experimental Therapeutics 2024; 391(2): 241 doi: 10.1124/jpet.123.002037
|
3 |
Koorosh Tabatabaei, Sara Moazzezi, Mohammadreza Emamgholizadeh, Haleh Vaez, Behzad Baradaran, Behrooz Shokouhi. Improved Therapeutic Efficacy of Doxorubicin Chemotherapy With Cannabidiol in 4T1 Mice Breast Cancer Model. Cancer Medicine 2024; 13(21) doi: 10.1002/cam4.70395
|
4 |
Abdul Quaiyoom, Ranjeet Kumar. An Overview of Diabetic Cardiomyopathy. Current Diabetes Reviews 2024; 20(5) doi: 10.2174/0115733998255538231001122639
|